Texting Intervention for Diabetes
(DD-TXT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help Veterans with type 2 diabetes manage their condition better using text messages. Participants will receive either a standard daily educational text or a more interactive and customizable text service (DD-TXT) that includes personalized reminders and motivational messages. The goal is to determine which texting method more effectively supports diabetes management. Veterans with type 2 diabetes who regularly visit VA outpatient services and have struggled with blood sugar control might be a good fit for this trial. As an unphased trial, this study offers Veterans a unique opportunity to explore innovative ways to manage their diabetes through personalized support.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on using a texting system to support diabetes management, so it's likely you can continue your current treatment.
What prior data suggests that this texting intervention is safe for diabetes self-management?
Previous studies have shown that similar text message support systems for managing diabetes have been well-received by participants. For example, one study found that using mobile phone support in diabetes programs across different countries was both safe and appreciated by participants. No major problems related to these texting systems have been reported.
Another study demonstrated that text-based education for managing diabetes can help lower HbA1c levels, an important measure of blood sugar control, without causing harm. This indicates that these systems are not only safe but also beneficial for managing diabetes.
Overall, research shows that these texting systems are safe for use and can improve diabetes management.12345Why are researchers excited about this trial?
Researchers are excited about this texting intervention for diabetes because it offers a highly personalized and interactive approach to diabetes management, unlike traditional methods that often rely on static education or medication. The DSMS+ arm stands out by enabling two-way communication, allowing patients to receive and customize supportive messages about their self-management behaviors, which can include medication reminders and exercise prompts. This interactive element, combined with the option to receive peer-written messages, provides a more engaging and supportive environment for managing diabetes, potentially improving adherence and outcomes.
What evidence suggests that this trial's texting interventions could be effective for diabetes?
Research has shown that digital programs for managing diabetes can help people better control their blood sugar. These programs often use text messages and have been linked to improved health for those with type 2 diabetes. For instance, one study found that these digital programs not only improved blood sugar levels but also enhanced quality of life. Another study noted that these interventions helped lower A1c levels, a measure of long-term blood sugar control. In this trial, participants in the DSMS+ arm will receive a program that allows for two-way communication and personalization, potentially providing more support by letting participants customize messages to meet their personal health goals.678910
Who Is on the Research Team?
Stephanie L Shimada, PhD
Principal Investigator
VA Bedford HealthCare System, Bedford, MA
Are You a Good Fit for This Trial?
This trial is for Veterans with type 2 diabetes who have struggled to control their blood sugar levels. They must be scheduled for a future appointment, able to text, and not visually impaired. Participants need access to a cell phone or smartphone and at least four VA outpatient visits in the past year.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the DD-TXT or DSE texting protocol for diabetes self-management for 6 months
Follow-up
Participants are monitored for changes in HbA1c, self-reported adherence, diabetes distress, LDL, and blood pressure control
What Are the Treatments Tested in This Trial?
Interventions
- DD-TXT
- DSE
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor